ArticleCell death & disease2017

A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor.

Weitao Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.